Pharmafile Logo

Interpharm Consultancy

30 years’ experience of the European pharmaceutical industry in general and 20 years in generics in particular gives Interpharm the background to help you with whatever issues you may be facing. Whether you are thinking about: Business development, Introducing your generic products into Europe, Market intelligence and pricing, Assistance with product licensing (in or out), How to devise an effective defence strategy to protect your brands against generic competition or Bioequivalence studies for your generic developments, please contact us. We can also help with in-house training that is tailored to your company’s individual needs on topics such as understanding the generic market and the legal and IP issues that affect it.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

55 Northiam, Woodside Park, London, N12 7JH, United Kingdom
+44 (0)20 8446 5572

 Latest Content from PMHub 

MedscapeLIVE! to Host “Neurology Exchange” Virtual Conference

Press Releases | September 10, 2022 | Medscape Education

Leading Neurology Faculty to Present Clinical Updates and Management Strategies for Key Neurological Conditions

Biotech Innovation in the Time of COVID-19

Videos and Podcasts | September 8, 2022 | Impetus Digital

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Geoff Thorne joins FH as Chief Technology Officer to drive innovation for clients

Press Releases | September 7, 2022 | Avalere Health

The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to meet our clients’ evolving needs.

New syndicated patient reports –

White Papers and Resources | September 7, 2022 | Inizio

Living with Uterine Fibroids and Endometriosis US 2022

Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access

Press Releases | September 6, 2022 | OPEN Health

OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.

Medscape: Education that delivers skin in the game #EADVCongress

Press Releases | September 6, 2022 | Medscape Education

Medscape Education Global to Present Symposia and Posters at the European Academy of Dermatology and Venereology 2022 (EADV)

New independent survey shows strong Medscape Professional Network usage among UK doctors

Press Releases | September 5, 2022 | Medscape Education

The latest results of the GP and Hospital Doctor Media Surveys reveal that the Medscape Professional Network* (MPN) is amongst the leading destinations for doctors in the UK. Of those surveyed,...

Medscape Oncology: at the core of cancer education #ESMO22

Press Releases | September 5, 2022 | Medscape Education

Medscape Education Global to Deliver Educational Opportunities at European Society for Medical Oncology (ESMO) 2022

Genesis Research and Syapse combine forces to offer RWE and data to oncology innovators

Genesis Research is delighted to announce a strategic partnership with Syapse®, combining the expertise and resources of both companies to better serve clients that are developing new oncology innovations.